{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T10:39:26Z","timestamp":1776681566608,"version":"3.51.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2022YFS0093"],"award-info":[{"award-number":["2022YFS0093"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Graft-derived cell-free DNA (GcfDNA) is a promising non-invasive biomarker for detecting allograft injury. In this study, we aimed to evaluate the efficacy of programmed monitoring of GcfDNA for identifying BK polyomavirus-associated nephropathy (BKPyVAN) in kidney transplant recipients. We recruited 158 kidney transplant recipients between November 2020 and December 2021. Plasma GcfDNA was collected on the tenth day, first month, third month, and sixth month for programmed monitoring and one day before biopsy. \u0394GcfDNA (cp\/mL) was obtained by subtracting the baseline GcfDNA (cp\/mL) from GcfDNA (cp\/mL) of the latest programmed monitoring before biopsy. The receiver operating characteristic curve showed the diagnostic performance of GcfDNA (cp\/mL) at biopsy time and an optimal area under the curve (AUC) of 0.68 in distinguishing pathologically proven BKPyVAN from pathologically unconfirmed BKPyVAN. In contrast, \u0394GcfDNA (cp\/mL) had a sensitivity and specificity of 80% and 84.6%, respectively, and an AUC of 0.83. When distinguishing clinically diagnosed BKPyVAN from clinical excluded BKPyVAN, the AUC of GcfDNA (cp\/mL) was 0.59 at biopsy time, and \u0394GcfDNA (cp\/mL) had a sensitivity and specificity of 81.0% and 76.5%, respectively, and an AUC of 0.81. Plasma \u0394GcfDNA (cp\/mL) was not significantly different between TCMR [0.15 (0.08, 0.24) cp\/mL] and pathologically proven BKPyVAN[0.34 (0.20, 0.49) cp\/mL]. In conclusion, we recommend programmed monitoring of plasma GcfDNA levels after a kidney transplant. Based on our findings from the programmed monitoring, we have developed a novel algorithm that shows promising results in identifying and predicting BKPyVAN.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1006970","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T11:21:35Z","timestamp":1665055295000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Detection of BK polyomavirus-associated nephropathy using plasma graft-derived cell-free DNA: Development of a novel algorithm from programmed monitoring"],"prefix":"10.3389","volume":"13","author":[{"given":"Jingyu","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongcun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu023","article-title":"BK virus infection: an update on diagnosis and treatment","volume":"30","author":"Sawinski","year":"2015","journal-title":"Nephrology dialysis Transplant Off Publ Eur Dialysis Transplant Assoc - Eur Renal Assoc"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0000000000000429","article-title":"BK virus as a mediator of graft dysfunction following kidney transplantation","volume":"22","author":"Yi","year":"2017","journal-title":"Curr Opin Organ Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1013924108","article-title":"Universal noninvasive detection of solid organ transplant rejection","volume":"108","author":"Snyder","year":"2011","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B4","doi-asserted-by":"publisher","first-page":"241ra277","DOI":"10.1126\/scitranslmed.3007803","article-title":"Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection","volume":"6","author":"De Vlaminck","year":"2014","journal-title":"Sci Trans Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e1002286","DOI":"10.1371\/journal.pmed.1002286","article-title":"A noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study","volume":"14","author":"Sch\u00fctz","year":"2017","journal-title":"PloS Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol JASN"},{"key":"B7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jcm8010019","article-title":"Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR","volume":"8","author":"Sigdel","year":"2018","journal-title":"J Clin Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00342","article-title":"Diagnostic performance of donor-derived plasma cell-free DNA fraction for antibody-mediated rejection in post renal transplant recipients: A prospective observational study","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15416","article-title":"Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study","volume":"19","author":"Oellerich","year":"2019","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surgeons"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15142","article-title":"Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction","volume":"19","author":"Whitlam","year":"2019","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surgeons"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e679","DOI":"10.1097\/TXD.0000000000001135","article-title":"Causes of renal allograft injury in recipients with normal donor-derived cell-free DNA","volume":"7","author":"Xie","year":"2021","journal-title":"Transplant direct"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvac053","article-title":"Using both plasma and urine donor-derived cell-free DNA to identify various renal allograft injuries","volume":"68","author":"Chen","year":"2022","journal-title":"Clin Chem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01763","article-title":"Urine donor-derived cell-free DNA helps discriminate BK polyomavirus-associated nephropathy in kidney transplant recipients with BK polyomavirus infection","volume":"11","author":"Chen","year":"2020","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1097\/TXD.0000000000001061","article-title":"Donor-derived cell-free DNA and the prediction of BK virus-associated nephropathy","volume":"6","author":"Kant","year":"2020","journal-title":"Transplant direct"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e14785","DOI":"10.1111\/ctr.14785","article-title":"Levels of donor-derived cell-free DNA and chemokines in BK polyomavirus-associated nephropathy","volume":"27","author":"Mayer","year":"2022","journal-title":"Clin Transplant"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e568","DOI":"10.1097\/TXD.0000000000001019","article-title":"Donor-derived cell-free DNA in infections in kidney transplant recipients: Case series","volume":"6","author":"Goussous","year":"2020","journal-title":"Transplant direct"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e13528","DOI":"10.1111\/ctr.13528","article-title":"BK polyomavirus in solid organ transplantation-guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Hirsch","year":"2019","journal-title":"Clin Transplant"},{"key":"B18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The banff 2017 kidney meeting report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surgeons"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12110","article-title":"BK polyomavirus in solid organ transplantation","author":"Hirsch","year":"2013","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surgeons"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14638","article-title":"Use of graft-derived cell-free DNA as a novel biomarker to predict allograft function after kidney transplantation","volume":"28","author":"Di","year":"2021","journal-title":"Int J Urol Off J Japanese Urological Assoc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15289","article-title":"Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients","volume":"19","author":"Huang","year":"2019","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surgeons"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/tri.13341","article-title":"Dynamics of early post-operative plasma ddcfDNA levels in kidney transplantation: a single-center pilot study","volume":"32","author":"Shen","year":"2019","journal-title":"Transplant Int Off J Eur Soc Organ Transplant"},{"key":"B23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.kint.2021.11.034","article-title":"Clinical outcomes from the assessing donor-derived cell-free DNA monitoring insights of kidney allografts with longitudinal surveillance (ADMIRAL) study","volume":"101","author":"Bu","year":"2022","journal-title":"Kidney Int"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz091","article-title":"The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation","volume":"35","author":"Gielis","year":"2020","journal-title":"Nephrology dialysis Transplant Off Publ Eur Dialysis Transplant Assoc - Eur Renal Assoc"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1038\/s41467-018-04745-0","article-title":"Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract","volume":"9","author":"Burnham","year":"2018","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1508736112","article-title":"Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments","volume":"112","author":"Sun","year":"2015","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.14010820","article-title":"Urinary cell mRNA profiles predictive of human kidney allograft status","volume":"16","author":"Lubetzky","year":"2021","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B2100131","article-title":"Urinary donor-derived cell-free DNA as a non-invasive biomarker for BK polyomavirus-associated nephropathy","volume":"22","author":"Shen","year":"2021","journal-title":"J Zhejiang Univ Sci B"},{"key":"B29","doi-asserted-by":"publisher","first-page":"10448","DOI":"10.3389\/ti.2022.10448","article-title":"Donor derived cell free DNA in kidney transplantation: The circa 2020-2021 update","volume":"35","author":"Kant","year":"2022","journal-title":"Transplant Int Off J Eur Soc Organ Transplant"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4258\/hir.2017.23.4.277","article-title":"Prediction of kidney graft rejection using artificial neural network","volume":"23","author":"Tapak","year":"2017","journal-title":"Healthcare Inf Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1006970\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T11:21:38Z","timestamp":1665055298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1006970\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2022.1006970"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1006970","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]},"article-number":"1006970"}}